Bristol Myers Squibb Repotrectinib application to treat cancer validated by EMA
Bristol Myers Squibb's application to use repotrectinib to treat cancer has been…
From Last Resort to Mainstay: The Evolution of ECMO in Critical Care
The Wall Street Journal article discusses the ethical considerations for hospitals regarding…
Veradigm acquires Koha Health as stockholder lawsuit filed
Veradigm, a healthcare technology company, acquired revenue cycle optimization platform Koha Health.…
California Is Poised to Protect Workers From Extreme Heat — Indoors
Workers in Southern California face dangerous temperatures year-round, particularly in warehouses. Lack…
Human growth hormone therapy linked with pediatric tibial physeal avulsion fractures
A study conducted at the Hospital for Special Surgery found an increased…
Biotech veteran Harvey Berger to lead startup Kojin Therapeutics
Harvey Berger, a veteran biotech entrepreneur, is returning as CEO of Boston…
WHO announces committee for guidance on adult trans health
The World Health Organization has assembled a committee of 21 members, including…
Hearing aids may help those with hearing loss live longer, finds analysis
Approximately 40 million American adults have hearing loss, but only one in…
Eastern equine encephalitis virus study uncovers decoy molecule that protects against deadly brain infection
Researchers at Washington University School of Medicine in St. Louis have discovered…
